Ncardia appoints Andy Holt as Chief Commercial Officer
An iPSC technology leader taps industry veteran to drive growth in cell therapy and drug discovery markets.
List view / Grid view
An iPSC technology leader taps industry veteran to drive growth in cell therapy and drug discovery markets.
A new report says that the global lab automation market is set to grow significantly until 2031, due to advanced drug development.
MIT chemists have discovered a possible way to design drugs that could fight against drug resistance.
Research from the University of Copenhagen reveals how Deep Brain Stimulation treatment of walking problems in Parkinson’s disease could be optimised by targeting specific neurons in the brainstem.
Eli Lilly scientists report that they have designed, qualified and enabled a high-throughput plasmid purification and quantification workstation.
Long-awaited findings about cell differentiation will be relevant in understanding normal development and may also be useful in cancer research.
Researchers have been able to slow down the progression of glioblastoma in mice, the most common adult brain cancer.
Researchers have successfully generated organoids in suspension, offering the possibility of larger-scale experiments to study human development and disease.
Researchers have innovated the petri dish to be able to grow and age live brain cells from patients with neurological disorders.
Researchers at Mayo Clinic, US found that messenger RNA could be used at low doses to regenerate bones without side effects.
A new study has suggested that previous global research into the human microbiome is heavily biased in favour of wealthy countries such as the US and UK.
In a scientific first, researchers have discovered fundamental mechanisms by which the hippocampus region of the brain organises memories into sequences and how this can be used to plan future behaviour.
Researchers have identified potential age-related macular degeneration drugs using a novel stem-cell based research tool.
A recent study has shown that antiretroviral therapy timing impacts the animal version of HIV and latent tuberculosis.
New research has shown that one-time infusion of stem cells from bone marrow improves the survival of mice with sepsis.